Form 8-K - Current report:
SEC Accession No. 0001181431-10-002840
Filing Date
2010-01-13
Accepted
2010-01-13 11:38:40
Documents
3
Period of Report
2010-01-13
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FOR NASDAQ DELISTING, DEREGISTRATION AND PRESS RELEASE rrd262603.htm 8-K 17620
2 PRESS RELEASE OF TARGETED GENETICS CORPORATION DATED JANUARY 13, 2010 rrd262603_30849.htm EX-99.1 7405
3 IMAGE 619.JPG image619.jpg GRAPHIC. 23177
  Complete submission text file 0001181431-10-002840.txt   58750
Mailing Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101
Business Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101 2066237612
TARGETED GENETICS CORP /WA/ (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23930 | Film No.: 10524315
SIC: 2836 Biological Products, (No Diagnostic Substances)